Magrini A, Nicodemo S, Puoti C
Liver Unit, Marino General Hospital, Rome, Italy.
Liver. 1996 Dec;16(6):377-9. doi: 10.1111/j.1600-0676.1996.tb00765.x.
To assess the hospital prevalence of asymptomatic primary biliary cirrhosis (PBC), routine determination of serum alkaline phosphatase (AP), liver function tests (albumin, bilirubin, prothrombin time) and serum liver biochemistry (aminotransferases, gamma-glutamyltranspeptidase) were performed in 4468 consecutive in-patients (2332 men, 2136 women; mean age 57 years, range 16-94 years) admitted to our medical department from April 1991 to May 1995. In patients with an increase of serum AP levels, antimitochondrial antibody (AMA) testing, ultrasonography or CT scan, HIDA biliary scintiscan, bone scintiscan and endoscopic retrograde cholangio-pancreatography (ERCP) were performed to exclude any disorders other than PBC. Fourteen out of the 4468 patients (0.3%) showed an asymptomatic increase of AP levels (i.e., detected by chance at the entry and not earlier investigated). In 12 of 14 cases the increase of AP was not related to PBC. Asymptomatic PBC was found in 2 of 4468 patients (0.04%). When only the "risk group" (women over 40 years) is considered, the prevalence rate increases to 0.12% (2/1644 women). Our data, while not assessing the true prevalence of asymptomatic PBC in the general population, suggest that symptomless PBC is much more common than has been thus far supposed.
为评估无症状原发性胆汁性肝硬化(PBC)在医院中的患病率,对1991年4月至1995年5月期间连续入住我院内科的4468例住院患者(2332例男性,2136例女性;平均年龄57岁,年龄范围16 - 94岁)进行了血清碱性磷酸酶(AP)、肝功能检查(白蛋白、胆红素、凝血酶原时间)及血清肝脏生化指标(转氨酶、γ-谷氨酰转肽酶)的常规检测。对于血清AP水平升高的患者,进行抗线粒体抗体(AMA)检测、超声或CT扫描、肝胆动态显像、骨显像及内镜逆行胰胆管造影(ERCP),以排除PBC以外的任何疾病。4468例患者中有14例(0.3%)表现为无症状的AP水平升高(即入院时偶然发现,此前未进行过更早的检查)。14例中有12例AP升高与PBC无关。4468例患者中有2例(0.04%)发现无症状PBC。若仅考虑“风险组”(40岁以上女性),患病率升至0.12%(2/1644名女性)。我们的数据虽未评估无症状PBC在普通人群中的真实患病率,但表明无症状PBC比迄今所认为的更为常见。